Scynexis (SCYX) Change in Account Payables (2023 - 2026)
Scynexis (SCYX) reported Change in Account Payables of $906000.0 for Q1 2026, up 555.28% on a YoY basis from $138262.3 in Q1 2025, and up 172.95% quarter-over-quarter from -$1.2 million in Q4 2025.
Scynexis (SCYX) Change in Account Payables (2023 - 2026) Analysis & Trends
Scynexis has reported Change in Account Payables for 4 years, with the latest figure at $906000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 555.28% year-over-year to $906000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.1 million (up 75.76% YoY), and the FY2025 full-year result was -$2.2 million, up 15.7% from the prior year.
- Change in Account Payables for Q1 2026 stood at $906000.0, up from -$1.2 million in the prior quarter.
- The five-year high for Change in Account Payables was $3.6 million in Q4 2023, with the low at -$3.6 million in Q2 2024.
- Historically, Change in Account Payables has averaged -$215846.2 across 4 years, with a median of -$199000.0 in 2025.
- The largest YoY upside for Change in Account Payables was 15175.0% in 2024 against a maximum downside of 650.0% in 2024.
- Scynexis' Change in Account Payables stood at $3.6 million in 2023, then tumbled by 113.37% to -$484000.0 in 2024, then plunged by 156.61% to -$1.2 million in 2025, then surged by 172.95% to $906000.0 in 2026.
- The last three Change in Account Payables figures came in at $906000.0 (Q1 2026), -$1.2 million (Q4 2025), and -$2.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 167.64 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 190,000.00 |
| 10 | Scynexis | 225.23 Mn | 165.97 Mn | - | 906,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 906,000.00 |
| Mar 31, 2026 | 906,000.00 |
| Dec 31, 2025 | -1.24 Mn |
| Dec 31, 2025 | -1.24 Mn |
| Sep 30, 2025 | -2.71 Mn |
| Sep 30, 2025 | -2.71 Mn |
| Jun 30, 2025 | 1.91 Mn |
| Jun 30, 2025 | 1.91 Mn |
| Mar 31, 2025 | -199,000.00 |
| Mar 31, 2025 | -199,000.00 |
| Dec 31, 2024 | -484,000.00 |
| Dec 31, 2024 | -484,000.00 |
| Sep 30, 2024 | -407,000.00 |
| Sep 30, 2024 | -407,000.00 |
| Jun 30, 2024 | -3.57 Mn |
| Jun 30, 2024 | -3.57 Mn |
| Mar 31, 2024 | 1.81 Mn |
| Mar 31, 2024 | 1.81 Mn |
| Dec 31, 2023 | 3.62 Mn |
| Dec 31, 2023 | 3.62 Mn |